Please login to the form below

Not currently logged in
Email:
Password:

NDA

This page shows the latest NDA news and features for those working in and with pharma, biotech and healthcare.

FDA turns down Celgene’s filing for multiple sclerosis drug

FDA turns down Celgene’s filing for multiple sclerosis drug

The embarrassing setback has arisen because of deficiencies in the “nonclinical and clinical pharmacology sections”of Celgene’s new drug application (NDA) for ozanimod, considered to be one of the most

Latest news

More from news
Approximately 0 fully matching, plus 141 partially matching documents found.

Latest Intelligence

  • Significant figures Significant figures

    a company right now is our NDA filing of ALIS in the US.”. ... Olaf said that ALIS’second NDA filing will most likely be in Japan due to its big NTM population and the regular frequency of physicians testing for NTM disease in patients.

  • Licensing

    Healthcare terms - Licensing.

  • Drug safety

    Healthcare terms - Drug safety.

  • Drug R&D

    Healthcare terms - Drug R&D.

  • Europe vs the US: New drug product approvals Europe vs the US: New drug product approvals

    For the past four years, NDA has analysed new drug approvals in the EU and the US. ... are regulatory affairs consultants and Johan Strömquist is CEO at NDA Group AB.

More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest appointments

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    Claes Buxfeldt joins NDA. He becomes its new HTA director. AstraZeneca’s former global price and reimbursement director Claes Buxfeldt has joined the NDA advisory board. ... Buxfeldt’s new role at NDA will see him drive and develop the group’s

  • NDA Group appoints Alison McGregor as its principal consultant NDA Group appoints Alison McGregor as its principal consultant

    NDA Group appoints Alison McGregor as its principal consultant. She joins the group following a new US office launch. ... Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new

  • Dr Paula Salmikangas joins NDA Group Dr Paula Salmikangas joins NDA Group

    Dr Paula Salmikangas joins NDA Group. Moves to the regulatory affairs consultancy from the Finnish Medicines Agency. ... UK-headquartered regulatory affairs consultancy the NDA Group has appointed Dr Paula Salmikangas as a director.

  • NDA Group appoints new vice president NDA Group appoints new vice president

    NDA Group appoints new vice president. Dr Werner Van den Eynde will also lead its advisory board. ... His new role will see him manage strategy operations and development of the NDA advisory board, including business development, sales, marketing and

  • NDA bolsters its senior team NDA bolsters its senior team

    NDA bolsters its senior team. Hires Eva Lilienberg, Christine Chirdo and Barbara Clendenen. ... Additionally, Christine Chirdo also joins the team as NDA’s new service area lead for high stakes meetings.

More from appointments
Approximately 7 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Weinberg Group

    The Weinberg Group is the global leader in regulatory and compliance services. We have provided biotech, medical device and pharmaceutical consulting services for over 30 years.

  • NDA

    NDA. NDA is Europe’ s leading regulatory affairs consultancy, providing clients with a unique insight into EU regulatory thinking and the best possible expert guidance and support to optimise the time ... Year on year, NDA has contributed towards more

  • Research and development

    NDA is Europe’ s leading regulatory affairs consultancy, providing clients with a unique insight into EU regulatory thinking and the best possible expert guidance and support to optimise the time to ... Year on year, NDA has contributed towards more

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics